Get App
Download App Scanner
Scan to Download
Advertisement

Dalmia Bharat, APL Apollo Among 12 Stocks Reviewed By HDFC Securities After Q2 Results; Check New Target Prices

For Dalmia Bharat, the brokerage continued with a Buy recommendation but reduced the target price to Rs 2,030 from Rs 2,110, citing pressure on margins and costs.

Dalmia Bharat, APL Apollo Among 12 Stocks Reviewed By HDFC Securities After Q2 Results; Check New Target Prices
Dalmia Bharat, Eris Life, Mankind Pharma and more on focus after Q2 results
(Photo: Unsplash)
STOCKS IN THIS STORY
Apollo Micro Systems Ltd.
--
Mastek Ltd.
--
Aavas Financiers Ltd.
--
Mankind Pharma Ltd
--
Eris Lifesciences Ltd.
--
Kajaria Ceramics Ltd.
--
APL Apollo Tubes Ltd.
--
Supreme Industries Ltd.
--
Bank Of Maharashtra
--
Bharat Petroleum Corporation Ltd.
--

BPCL, Mankind Pharma, Bank of Maharashtra, APL Apollo Tubes, Supreme Industries, Dalmia Bharat, Kajaria Ceramics, Apollo Micro Systems, Eris Lifesciences, Aditya Birla Real Estate, Aavas Financiers and Mastek were among the stocks reviewed by HDFC Securities following their September-quarter earnings, with the brokerage reiterating positive views on most names and upgrading Kajaria Ceramics to 'Buy'.

NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

HDFC Securities Instutitional Equities

BPCL, Mankind Pharma, Bank of Maharashtra, APL Apollo Tubes, Supreme Industries, Dalmia Bharat, Kajaria Ceramics, Apollo Micro Systems, Eris Lifesciences, Aditya Birla Real Estate, Aavas Financiers and Mastek were among the stocks reviewed by HDFC Securities following their September-quarter earnings, with the brokerage reiterating positive views on most names and upgrading Kajaria Ceramics to 'Buy'.

Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay

HDFC Securities maintained a Buy rating on BPCL while revising its target price lower to Rs 408 from Rs 430. The brokerage cited refining and petrochemicals growth drivers, though it trimmed earnings estimates amid likely pressure on marketing margins.

For Mankind Pharma, HDFC Securities retained its Add rating and revised the target price to Rs 2,610 from Rs 2,850 after factoring in the latest quarterly performance.

The brokerage reiterated Buy on Bank of Maharashtra and raised its target price to Rs 95 from Rs 90, supported by strong loan growth, margin expansion and improving asset quality.

On APL Apollo Tubes, HDFC Securities maintained its Buy call and increased the target price to Rs 2,450 from Rs 2,350, encouraged by record margins and a stronger value-added product mix.

ALSO READ | Mankind Pharma Q2 Review: Export Momentum Continues; Systematix Maintains 'Hold'; Check Target Price

Supreme Industries retained an Add rating with an unchanged target price of Rs 4,250, despite the company lowering its volume growth guidance for FY27.

For Dalmia Bharat, the brokerage continued with a Buy recommendation but reduced the target price to Rs 2,030 from Rs 2,110, citing pressure on margins and costs.

A key rating action came in Kajaria Ceramics, where HDFC Securities upgraded the stock to Buy from Add while maintaining its target price at Rs 1,390, backed by strong operational performance and healthy growth visibility.

The brokerage retained an Add rating on Apollo Micro Systems and increased the target price to Rs 460 from Rs 400, reflecting optimism around its order pipeline and earnings growth prospects.

For Eris Lifesciences, HDFC Securities maintained a Buy call while lowering the target price to Rs 1,500 from Rs 1,730 after revising earnings estimates.

The brokerage reiterated Buy on Aditya Birla Real Estate with an unchanged target price of Rs 1,910, citing a robust launch pipeline, GDV additions and a strengthened balance sheet.

Aavas Financiers also retained a Buy rating with an unchanged target price of Rs 1,540, as HDFC Securities sees improving loan growth and operational efficiency.

Lastly, HDFC Securities maintained its Buy recommendation on Mastek with an unchanged target price of Rs 1,920, supported by growth opportunities in the UK business and AI-led transformation initiatives.

Click on the attachment to read the full report:

Hdfc Sec.pdf
VIEW DOCUMENT

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.

Unlock the Full Story
with Premium Access
Already a subscriber? Sign In

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source
Loading PDF...
Listen to the latest songs, only on JioSaavn.com